Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy targets all dividing cells, causing side effects like nausea and hair loss.

Dihydrotestosterone treatment on 2D and 3D-cultured skin cells slows down hair growth by affecting certain genes and could be a potential target for hair loss treatment.

The treatment promotes hair growth, improves hair density, and reduces skin irritation.

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Aquaporins could be new drug targets for treating polycystic ovary syndrome.

AH-001 could be a safer and more effective treatment for hair loss.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.

Metabolic syndrome's individual issues are real and need treatment to reduce diabetes and heart disease risks.

Laser hair removal is now more effective, but the best treatment schedule is still uncertain.

Heat Shock Proteins are important in the development of Polycystic Ovarian Syndrome and could be targets for new treatments.

The study developed a 3D model that closely imitates remaining ovarian cancer after treatment and identified a potential drug targeting resistant cancer cells.

Using multiple treatments together works better for female hair loss than using one treatment alone.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

Key genes and pathways involved in thyroid eye disease were identified, aiding potential treatment and diagnosis.

KLF4 is important for maintaining stem cells and has potential in cancer treatment and wound healing.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.

Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.

A new protein linked to Alzheimer's was discovered, and a hair loss treatment showed effectiveness but had some sexual side effects.

Melasma is now considered a skin aging disorder caused by sun exposure in people with a genetic tendency, which impacts treatment and prevention approaches.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

Scarring alopecia affects different hair follicle stem cells than nonscarring alopecia, and the infundibular region could be a new treatment target.

HO-1 helps skin health and healing but can worsen melanoma; it's a potential treatment target for skin diseases.

Two elderly men developed scalp inflammation after using a gel for skin lesions, which healed with treatment except for some permanent hair loss.

Scientists found a new protein, AMY117, common in Alzheimer's patients, which could be important for treatment and diagnosis.

R-spondin2 may help treat hair loss, gene differences could explain baldness, a peptide's regulation is linked to psoriasis, B-defensin gene copies may affect a skin condition's risk and severity, and potential markers and targets for alopecia areata were identified.

Ketogenic diet, neurosteroids, and HMGB1-TLR4 signaling pathway are potential targets for new epilepsy treatments.

The Ar/miR-221/IGF-1 pathway is involved in male pattern baldness, with miR-221 potentially being a new target for treatment.